Antibody-Based Therapeutic Interventions for Amyotrophic Lateral Sclerosis: A Systematic Literature Review
Amyotrophic Lateral Sclerosis (ALS) is a mid-life onset neurodegenerative disease that manifests its symptomatology with motor impairments and cognitive deficits overlapping with Frontotemporal Lobar Degeneration (FTLD). The etiology of ALS remains elusive, with various mechanisms and cellular targe...
Guardado en:
Autores principales: | Amélie Poulin-Brière, Edris Rezaei, Silvia Pozzi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/677940c8688947009b4e499213572c04 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amyotrophic lateral sclerosis official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
Publicado: (2006) -
Amyotrophic lateral sclerosis and frontotemporal degeneration
Publicado: (2000) -
Amyotrophic lateral sclerosis and other motor neuron disorders official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
Publicado: (2005) -
A Platform to Understand Amyotrophic Lateral Sclerosis (ALS) and Extend Human Motor Neurons Longevity
por: Cáceres,D. E, et al.
Publicado: (2019) -
γ' Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis
por: Ana Catarina Pronto-Laborinho, et al.
Publicado: (2021)